Page last updated: 2024-10-21

pd 173074 and Achondroplasia

pd 173074 has been researched along with Achondroplasia in 2 studies

Achondroplasia: An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martin, L1
Kaci, N1
Estibals, V1
Goudin, N1
Garfa-Traore, M1
Benoist-Lasselin, C1
Dambroise, E1
Legeai-Mallet, L1
Gudernova, I1
Vesela, I1
Balek, L1
Buchtova, M1
Dosedelova, H1
Kunova, M1
Pivnicka, J1
Jelinkova, I1
Roubalova, L1
Kozubik, A1
Krejci, P1

Other Studies

2 other studies available for pd 173074 and Achondroplasia

ArticleYear
Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
    Human molecular genetics, 2018, 01-01, Volume: 27, Issue:1

    Topics: Achondroplasia; Animals; Bone Development; Carrier Proteins; Cartilage; Cell Differentiation; Cell L

2018
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
    Human molecular genetics, 2016, Jan-01, Volume: 25, Issue:1

    Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocyt

2016